Skip to main content
. 2012;34(6):430–435. doi: 10.5581/1516-8484.20120108

Table 2.

Nominal Logistic regression

  Lymphocyte recovery Day +30 Lymphocyte recovery Day +100
  p-value (OR; 95% CI) p-value (OR; 95% CI)
Age (≤ 9 vs. > 9 year old) 0.01 (2.23; 1.11-4.49)   0.3 (0.64; 0.28-1.49)  
Diagnosis (ALL vs. AML) 0.59 (1.2; 0.6-2.42)   0.01 (3.24; 1.12-11.6)  
Donor (related vs. non-related) 0.03 (2.22; 1.10-4.47)   0.04 (2.10; 1.08-4.79)  
Disease status (early vs. advanced) 0.02 (2.58; 1.27-5.23)   0.6 (1.18; 0.51-2.73)  
Stem cell source (CB vs. BM) 0.008 (0.30; 0.13-0.68)   0.58 (1.32; 0.47-3.71)  
ATG use (Yes vs. no) 0.62 (1.12; 0.56-2.62)   0.03 (2.61; 1.06-7.06)  

OR: Odds ratio; 95% CI: 95% confidence interval; ALL: acute lymphoblastic leukemia; AML: acute myeloid leukemia; CB: Cord blood; BM: bone marrow; ATG: antithymocyte globulin

p-value < 0.05 denotes significant difference